Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids

Journal of Asthma

Volumn 40, Issue 3, 2003, Pages 251-255

  Mirzaei, Siroos ^a   Zajicek, Hubert K ^c   Knoll, Peter ^a   Hahn, Marianne ^a   Levi, Moshe ^c   Köhn, Horst ^a   Pohl, Wolfgang ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Calcitriol; Corticosteroid treatment; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; PREDNISOLONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASTHMA; BONE MASS; CALCIUM BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; LUMBAR VERTEBRA; MALE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; CALCITRIOL; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PREDNISOLONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0038386070     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018319     Document Type: Article

References (20)

1. Jones G, Trafford DJH, Hollis BW, Makin HLJ. Vitamin D: cholecalciferol, ergocalciferol and hydroxylated metabolites. In: Nelis HJ, Lambert WE, DeLeenheer AP, eds. Modern Chromatographic Analysis of Vitamins. Vol. 30. 2nd ed. [Chromatographic Science Series]. New York: Marcel Dekker, 1992:73-151.
2. Jones Glenville, Hogan David B, Yendt Edmund, Hanley David A. Vitamin D metabolites and analogs in the treatment of osteoporosis. Can Med Assoc 1996; 155(7):955-961.
3. Haussler MR. Vitamin D receptors: nature and function. Annu Rev Nutr 1986; 6:527-562.
4. DeLuca HF. The vitamin D story: a collaborative effort of basis science and clinical medicine. FASEB J 1988; 2:224-236.
5. Abe E, Miyaura C, Tanaka H, Shiina Y, Kuribayashi T, Suda S, Nishii Y, DeLuca HF, Suda T. 1a,25-Dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci USA 1983; 80:5583-5587.
6. Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1983; 80:5907-5911.
7. Merke J, Klaus G, Hugel U, Waldherr R, Ritz E. No 1,25-dihydroxy D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest 1986; 77:312-314.
8. Pike JW. Vitamin D3 receptors: structure and function in transcription. Annu Rev Nutr 1991; 11:189-216.
9. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med 1990; 113:649-655.
10. Shiraki M, Ito H, Orimo H. The ultra long-term treatment of senile osteoporosis with 1 alphahydroxyvitamin D3. Bone Miner 1993; 20:223-234.
11. Tilyard MW, Spears GF, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326:357-362.
12. Gallagher JC, Riggs BL, Recker RR, Goldgar D. The effect of clacitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 1989; 191:287-292.
13. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988; 84:401-408.
14. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. Procter & Gamble Pharmaceuticals, Staines, UK. J Bone Miner Res 2000 Jun; 15(6):993-1000.
15. Sambrook PN, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993; 328:1747-1752.
16. Canalis EM. Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity and deoxyribonuleic acid content in cultured fetal rat calvariae. Endocrinology 1983; 112:931-939.
17. Sambrook PN. Corticosteroid induced osteoporosis. J Rheumatol 1996; 23(suppl 45):19-22.
18. Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L. The effect of high dose glucocorticoid administration on serum bone gamma carboxyglutamic acid containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Mineral 1988; 4:105-113.
19. Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs B. Intestinal calcium absorption in exogenous hypercorticoidism: Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977; 60:253-259.
20. Fogelman I, Blake GM. Different approaches to bone densitometry. J Nucl Med 2000; 41:2015-2025.